103 related articles for article (PubMed ID: 38726846)
1. Active surveillance and emerging medical treatment options for desmoid: when and for whom?
Bonvalot S; Miah A; Kasper B
Curr Opin Oncol; 2024 May; ():. PubMed ID: 38726846
[TBL] [Abstract][Full Text] [Related]
2. Desmoid tumors: who, when and how to treat?
Mikhael R; Smith M; Tzanis D; Watson S; Miah AB; Bonvalot S
Curr Opin Oncol; 2022 Jul; 34(4):335-341. PubMed ID: 35837705
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance.
van Houdt WJ; Husson O; Patel A; Jones RL; Smith MJF; Miah AB; Messiou C; Moskovic E; Al-Muderis O; Benson C; Zaidi S; Dunlop A; Strauss DC; Hayes AJ; van der Graaf WTA
Ann Surg Oncol; 2019 Dec; 26(13):4699-4706. PubMed ID: 31531797
[TBL] [Abstract][Full Text] [Related]
5. Current management and recent progress in desmoid tumors.
Zhou MY; Bui NQ; Charville GW; Ghanouni P; Ganjoo KN
Cancer Treat Res Commun; 2022; 31():100562. PubMed ID: 35460976
[TBL] [Abstract][Full Text] [Related]
6. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M; Ratan R; Alcindor T; Schöffski P; van der Graaf WT; Wilky BA; Riedel RF; Lim A; Smith LM; Moody S; Attia S; Chawla S; D'Amato G; Federman N; Merriam P; Van Tine BA; Vincenzi B; Benson C; Bui NQ; Chugh R; Tinoco G; Charlson J; Dileo P; Hartner L; Lapeire L; Mazzeo F; Palmerini E; Reichardt P; Stacchiotti S; Bailey HH; Burgess MA; Cote GM; Davis LE; Deshpande H; Gelderblom H; Grignani G; Loggers E; Philip T; Pressey JG; Kummar S; Kasper B
N Engl J Med; 2023 Mar; 388(10):898-912. PubMed ID: 36884323
[TBL] [Abstract][Full Text] [Related]
7. Desmoid-type fibromatosis: toward a holistic management.
Penel N; Kasper B; van Der Graaf WTA
Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
[TBL] [Abstract][Full Text] [Related]
8. Desmoid Tumors: Current Perspective and Treatment.
Mangla A; Agarwal N; Schwartz G
Curr Treat Options Oncol; 2024 Feb; 25(2):161-175. PubMed ID: 38270798
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of desmoid tumors is safe and effective.
Park JS; Nakache YP; Katz J; Boutin RD; Steffner RJ; Monjazeb AM; Canter RJ
J Surg Res; 2016 Sep; 205(1):115-20. PubMed ID: 27621007
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
[TBL] [Abstract][Full Text] [Related]
11. Upfront surgery is not advantageous compared to more conservative treatments such as observation or medical treatment for patients with desmoid tumors.
Tsukamoto S; Tanzi P; Mavrogenis AF; Akahane M; Kido A; Tanaka Y; Cesari M; Donati DM; Longhi A; Errani C
BMC Musculoskelet Disord; 2021 Jan; 22(1):12. PubMed ID: 33402184
[TBL] [Abstract][Full Text] [Related]
12. Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
Bonvalot S; Cozic N; Le Cesne A; Blay JY; Penel N; Fau M; Chevreau C; Anract P; Waast D; Laurence V; Watson S; Duffaud F; Gouin F; Taieb S; Kind M; Lam L
Ann Surg Oncol; 2023 Dec; 30(13):8653-8659. PubMed ID: 37777684
[TBL] [Abstract][Full Text] [Related]
13. Desmoid Tumors in the Active Surveillance Era: Evaluation of Treatment Options and Pain Relief in a Single-Center Retrospective Analysis.
Rastrelli M; Chiusole B; Cavallin F; Del Fiore P; Angelini A; Cerchiaro MC; Ruggieri P; Sbaraglia M; Mocellin S; Brunello A
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138880
[TBL] [Abstract][Full Text] [Related]
14. Evolving Practice Patterns Over Two Decades (1993-2013) in the Management of Desmoid-type Fibromatosis in British Columbia.
de Bruyns A; Li H; MacNeil A; Simmons C; Clarkson P; Goddard K; Munk PL; Hart JJ; Holloway C; Truong P; Feng X
Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e102-e110. PubMed ID: 31685376
[TBL] [Abstract][Full Text] [Related]
15. A cost analysis of sorafenib for desmoid tumors.
Johns MS; Merritt WT; Rhodes L; Ford CN; Thompson M; Lee WM; Sheldon Y; Petrelli NJ; Tiesi GJ
J Oncol Pharm Pract; 2023 Apr; 29(3):663-668. PubMed ID: 35112974
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of low-power cumulative high-intensity focused ultrasound treatment for recurrent desmoid tumor.
Zhong X; Hu X; Zhao P; Wang Y; Fang XF; Shen J; Shen H; Yuan Y
Cancer Med; 2022 May; 11(10):2079-2084. PubMed ID: 35274811
[TBL] [Abstract][Full Text] [Related]
17. Activity of Sorafenib against desmoid tumor/deep fibromatosis.
Gounder MM; Lefkowitz RA; Keohan ML; D'Adamo DR; Hameed M; Antonescu CR; Singer S; Stout K; Ahn L; Maki RG
Clin Cancer Res; 2011 Jun; 17(12):4082-90. PubMed ID: 21447727
[TBL] [Abstract][Full Text] [Related]
18. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Desmoid Tumor Therapy.
Napolitano A; Mazzocca A; Spalato Ceruso M; Minelli A; Baldo F; Badalamenti G; Silletta M; Santini D; Tonini G; Incorvaia L; Vincenzi B
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32752153
[TBL] [Abstract][Full Text] [Related]
20. Desmoid-Type Fibromatosis.
Garcia-Ortega DY; Martín-Tellez KS; Cuellar-Hubbe M; Martínez-Said H; Álvarez-Cano A; Brener-Chaoul M; Alegría-Baños JA; Martínez-Tlahuel JL
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
